These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 17001234

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.
    Am J Cardiol; 2012 Jan 01; 109(1):67-74. PubMed ID: 21943940
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL, Zhang J, Yei F, Zhu Z, Liu Z, Lin S, Chu J, Yan J, Zhang R, Kwan TW.
    Int J Cardiol; 2008 Jun 06; 126(3):407-13. PubMed ID: 17651830
    [Abstract] [Full Text] [Related]

  • 6. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
    Jabara R, Gadesam RR, Pendyala LK, Knopf WD, Chronos N, Chen JP, Viel K, King SB, Manoukian SV.
    Am J Cardiol; 2009 Jun 15; 103(12):1657-62. PubMed ID: 19539072
    [Abstract] [Full Text] [Related]

  • 7. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
    Feldkamp T, Baumgart D, Elsner M, Herget-Rosenthal S, Pietruck F, Erbel R, Philipp T, Kribben A.
    Clin Nephrol; 2006 Nov 15; 66(5):322-30. PubMed ID: 17140161
    [Abstract] [Full Text] [Related]

  • 8. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L, Falsini G, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.
    J Cardiovasc Med (Hagerstown); 2010 Mar 15; 11(3):199-206. PubMed ID: 19829124
    [Abstract] [Full Text] [Related]

  • 9. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
    Shema-Didi L, Kristal B, Eizenberg S, Marzuq N, Sussan M, Feldman-Idov Y, Ofir P, Atar S.
    Nephrology (Carlton); 2016 Apr 15; 21(4):295-300. PubMed ID: 26370061
    [Abstract] [Full Text] [Related]

  • 10. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI, Cho YS, Cho GY, Chae IH, Kim CH.
    Am J Cardiol; 2011 Jul 15; 108(2):189-94. PubMed ID: 21545991
    [Abstract] [Full Text] [Related]

  • 11. Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions.
    Li WH, Li DY, Han F, Xu TD, Zhang YB, Zhu H.
    Int Urol Nephrol; 2013 Aug 15; 45(4):1065-70. PubMed ID: 23225080
    [Abstract] [Full Text] [Related]

  • 12. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M, Radovic M, Kühnle Y, Combé V, Waigand J, Schröder S, Dietz R, Frei U, Eckardt KU.
    Nephrol Dial Transplant; 2008 May 15; 23(5):1588-94. PubMed ID: 18175785
    [Abstract] [Full Text] [Related]

  • 13. Novel risk score of contrast-induced nephropathy after percutaneous coronary intervention.
    Ji L, Su X, Qin W, Mi X, Liu F, Tang X, Li Z, Yang L.
    Nephrology (Carlton); 2015 Aug 15; 20(8):544-51. PubMed ID: 25706048
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Lin KY, Zheng WP, Bei WJ, Chen SQ, Islam SM, Liu Y, Xue L, Tan N, Chen JY.
    Int J Cardiol; 2017 Mar 01; 230():402-412. PubMed ID: 28043662
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G, Baber U, Mastoris I, Vlachojannis GJ, Yu J, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Nikolsky E, Wong SC, Theodoropoulos KN, Dangas GD, Mehran R.
    Catheter Cardiovasc Interv; 2016 Mar 01; 87(4):703-9. PubMed ID: 26481591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.